4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-009000
President and CEO bought 6,400 shares at $1.53 ($9,792)
- President and CEO gave up 5,343 shares (to pay taxes)
- President and CEO acquired 15,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-31 | Exercise or conversion : show line 1 in the form | +15,450 | 96,730 | D | ||
| 2022-03-31 | Shares withheld for taxes : show line 2 in the form | −5,343 | $1.54 | $8,228 | 91,387 | D |
| 2022-03-31 | Purchase : show line 3 in the form | +6,400 | $1.53 | $9,792 | 97,787 | D |
| Open-market purchases · 6,400 sh · avg $1.53 · $9,792 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-31 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −15,450 | 15,450 | D |
Loading xslF345X03/ownership.xml…